BILR-355

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Investigational

Details

Stereochemistry	ACHIRAL
Molecular Formula	C25H23N5O3
Molecular Weight	441.4818
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of BILR-355

Structure Search

SMILES

CCN1C2=NC=CC=C2N(C)C(=O)C3=C1N=CC(CCOC4=C5C=CC=CC5=[N+]([O-])C=C4)=C3

InChI

InChIKey=BEMBRAMZGVDPMH-UHFFFAOYSA-N

InChI=1S/C25H23N5O3/c1-3-29-23-19(25(31)28(2)21-9-6-12-26-24(21)29)15-17(16-27-23)11-14-33-22-10-13-30(32)20-8-5-4-7-18(20)22/h4-10,12-13,15-16H,3,11,14H2,1-2H3

HIDE SMILES / InChI

Molecular Formula	C25H23N5O3
Molecular Weight	441.4818
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:14:03 GMT 2025` Edited by `admin` on `Mon Mar 31 18:14:03 GMT 2025`
Record UNII	V7T28EEE1C
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

6H-DIPYRIDO(3,2-B:2',3'-E)(1,4)DIAZEPIN-6-ONE, 11-ETHYL-5,11-DIHYDRO-5-METHYL-8-(2-((1-OXIDO-4-QUINOLINYL)OXY)ETHYL)-

Preferred Name

English

BILR-355

Common Name

English

Code System Code Type Description

CAS

380378-81-4

Created by admin on Mon Mar 31 18:14:03 GMT 2025 , Edited by admin on Mon Mar 31 18:14:03 GMT 2025

PRIMARY

FDA UNII

V7T28EEE1C

Created by admin on Mon Mar 31 18:14:03 GMT 2025 , Edited by admin on Mon Mar 31 18:14:03 GMT 2025

PRIMARY

PUBCHEM

3010663

Created by admin on Mon Mar 31 18:14:03 GMT 2025 , Edited by admin on Mon Mar 31 18:14:03 GMT 2025

PRIMARY

EPA CompTox

DTXSID30191455

Created by admin on Mon Mar 31 18:14:03 GMT 2025 , Edited by admin on Mon Mar 31 18:14:03 GMT 2025

PRIMARY

SMS_ID

300000042443

Created by admin on Mon Mar 31 18:14:03 GMT 2025 , Edited by admin on Mon Mar 31 18:14:03 GMT 2025

PRIMARY

Related Record Type Details


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MAJOR


					859A956UY8

HUMAN IMMUNODEFICIENCY VIRUS TYPE 1

TARGET ORGANISM->INHIBITOR

Comments:

The in vitro results showed that the EC50 of BILR 355 was 0.26 ng/ml (0.59 nM) against wild-type HIV-1 and ranged from 1.5 to 13 ng/ml (3.4 –29 nM) against clinically common single and double NNRTI mutations .

Amount:

Related Record Type Details


					6B0S1I43SR

BI-211136

METABOLITE -> PARENT

Comments:

IN VITRO


					S8ARM0OC4R

BI-212580

METABOLITE -> PARENT

Comments:

IN VITRO


					C87129B63N

BIRK-122

METABOLITE -> PARENT

Comments:

IN VITRO


					1XNQ7Z4FOO

6H-DIPYRIDO(3,2-B:2',3'-E)(1,4)DIAZEPIN-6-ONE, 5,11-DIHYDRO-11-(2-HYDROXYETHYL)-5-METHYL-8-(2-((1-OXIDO-4-QUINOLINYL)OXY)ETHYL)-

METABOLITE -> PARENT

Comments:

IN VITRO


					6B3VGS0GVY

BILR-564

METABOLITE -> PARENT

Comments:

IN VITRO


					ELU5MN8O7A

INLA-1678

METABOLITE -> PARENT

Comments:

IN VITRO


					MJN1XKK9VY

INRF-105

METABOLITE -> PARENT

Comments:

IN VITRO


					07P15H18XP

BI-212578

METABOLITE -> PARENT

Comments:

IN VITRO


					51V5RRE3HM

BILR-516

METABOLITE -> PARENT


					UYH0SG22VG

11-ETHYL-5,11-DIHYDRO-8-(2-HYDROXYETHYL)-6H-DIPYRIDO(3,2-B:2',3'-E)(1,4)DIAZEPIN-6-ONE

METABOLITE -> PARENT

Comments:

IN VITRO


					3FS2A1V9UL

EXLS-1451

METABOLITE -> PARENT

Comments:

IN VITRO


					PG76HAS2AD

.BETA.-D-GLUCOPYRANOSIDURONIC ACID, 2-(8-(2-((1,2-DIHYDRO-2-OXO-4-QUINOLINYL)OXY)ETHYL)-5,6-DIHYDRO-5-METHYL-6-OXO-11H-DIPYRIDO(3,2-B:2',3'-E)(1,4)DIAZEPIN-11-YL)ETHYL

METABOLITE -> PARENT

Comments:

IN VITRO


					T7VD4C7353

4-(2-(11-(2-(((2R,3R,4S,5S,6S)-6-CARBOXY-3,4,5-TRIHYDROXYTETRAHYDRO-2H-PYRAN-2-YL)OXY)ETHYL)-5-METHYL-6-OXO-6,11-DIHYDRO-5H-DIPYRIDO(3,2-B:2',3'-E)(1,4)DIAZEPIN-8-YL)ETHOXY)QUINOLINE 1-OXIDE

METABOLITE -> PARENT

Comments:

IN VITRO

Related Record Type Details


					V7T28EEE1C

BILR-355

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Biological Half-life	PHARMACOKINETIC				ORAL ADMINISTRATION

Tmax	PHARMACOKINETIC				ORAL ADMINISTRATION SINGLE DOSE